BIOHARVEST SCIENCES INC. (BHST)

↓ Download CSV

CIK 0001723464 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated A1
  • Fiscal year ends Dec 31

In fiscal 2025, BIOHARVEST SCIENCES INC. reported revenue of $34.51M, up 37.0% from the prior year. The company ran a net loss, with a net margin of -32.3%.

Key ratios (FY2025)

-16.2%
Operating margin
-32.3%
Net margin
-43.8%
Return on equity
+37.0%
Revenue growth (YoY)
Metric (FY)202520242023
Revenue$34.51M$25.19M$12.67M
Cost of Revenue$14.03M$11.25M$7.04M
Operating Income-$5.58M-$6.99M-$9.97M
Net Income-$11.13M-$12.91M-$12.56M
EPS (Diluted)$-0.60$-0.80$-0.93
Shareholders' Equity$25.45M$1.33M-$14.85M
Cash & Equivalents$23.02M$2.39M$5.36M
Operating Cash Flow-$7.23M-$6.68M-$8.52M
Capital Expenditures$2.35M$2.83M$1.47M